A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04572152 |
|
Recruitment Status :
Active, not recruiting
First Posted : October 1, 2020
Last Update Posted : January 6, 2023
|
Sponsor:
Akeso
Information provided by (Responsible Party):
Akeso
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | December 8, 2022 |
| Estimated Study Completion Date : | October 2023 |